GEn1E Lifesciences

Developer of artificial intelligence-powered precision therapies designed to address immunology, inflammatory, rare, and oncologic diseases. The company offers a proprietary drug development model tha...

Healthcare

Palo Alto, CA, United States

Founded 2018

6 employees

Website

Valuation

$141M

Market implied

Share Price

N/A

Total Raised

$31.5M

Last Round

N/A

Investors

+37 other investors

View all 37 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock GEn1E Lifesciences's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required